发明名称 ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for oral administration of bendamustine that is excellent in solubility.SOLUTION: Bendamustine or a pharmaceutically acceptable ester, salt, or solvate thereof and a pharmaceutically acceptable excipient are contained. The excipient is a polyethoxylated castor oil or a block copolymer of ethylene oxide and propylene oxide, or e.g., is selected from the group consisting of saccharides, such as mannitol, and a pharmaceutically acceptable saccharide, such as microcrystalline cellulose, e.g., has a mass ratio of an active ingredient to the sugar excipient of 1:1-5. The pharmaceutical composition has a pH of 1.5 in a 500 ml dissolution medium, and exhibits the dissolution of bendamustine of at least 60% after 20 minutes, 70% after 40 minutes, and 80% after 60 minutes when measuring using a paddle apparatus at 50 rpm based on European Pharmacopoeia.SELECTED DRAWING: None
申请公布号 JP2016172763(A) 申请公布日期 2016.09.29
申请号 JP20160112212 申请日期 2016.06.03
申请人 ASTELLAS DEUTSCHLAND GMBH 发明人 ULRICH PATZAK;TAOUFIK OUATAS
分类号 A61K31/4184;A61K9/20;A61K9/66;A61K31/282;A61K31/475;A61K31/573;A61K31/704;A61K33/24;A61K39/395;A61K47/10;A61K47/14;A61K47/26;A61K47/34;A61K47/38;A61K47/40;A61K47/44;A61P35/00;A61P35/02 主分类号 A61K31/4184
代理机构 代理人
主权项
地址